CROI (Conference on Retroviruses and Opportunistic Infections)

The Latest

Staying on PrEP is Significantly Different for PrEP Users With Commercial Insurance Versus Medicaid

Young adults, blacks, cisgender women, and people in rural areas, as well as people on Medicaid, were less likely to persist on PrEP.

By Stephen Hicks

Insurers and Pharmas Must Help Fix HIV Drug Pricing System, Advocates Say

The Fair Pricing Coalition is working with pharmaceutical companies to ensure fair prices for new HIV drugs on par with those of older medications.

By Barbara Jungwirth

Separate and Unequal Access Frames Discussion at CROI Panel on U.S. HIV Care Cascade

The lack of Medicaid expansion in the South is creating worse racial disparities in the U.S., according to researchers and medical providers discussing the HIV care cascade at CROI 2018.

By Kenyon Farrow

ACA's Medicaid Expansion Significantly Increased Coverage and Clinical Outcomes for People With HIV

Due to the impact of the Affordable Care Act (ACA), in just two years the proportion of people living with HIV in care covered by Medicaid increased from 36% to 42% and the proportion that were uninsured fell from 18% to 14%.

By Roger Pebody

The Need to Advocate for Fair HIV Drug Prices

"Drug prices are too high and your access to your drugs is in danger. So, wake up and get ready!" says Lynda Dee of the Fair Pricing Coalition.

By Barbara Jungwirth

New Antiretrovirals Could Mean Savings Up to $3 Billion by 2025

The introduction of three new antiretrovirals into treatment programmes in low- and middle-income countries -- tenofovir alafenamide fumarate (TAF), low-dose efavirenz (Sustiva, Stocrin) and dolutegravir (Tivicay, DTG) -- could represent over $3 bill...

By Polly Clayden for HIV i-Base

CROI 2014: Fair Pricing Coalition Seeks to Increase Access to HIV and HCV Treatment (Video)

Lynda Dee of the Fair Pricing Coalition (FPC) spoke with coworkers Jeff Berry and Murray Penner, as well as David Evans of Project Inform, about access to HIV and hepatitis C (HCV) medications. FPC negotiates with pharmaceutical companies to make the...

By Barbara Jungwirth